MARÍA SONIA
GAZTAMBIDE SÁENZ
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (21)
2024
-
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433
2021
-
Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study
Scientific Reports, Vol. 11, Núm. 1
2020
-
Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study
BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1
2019
-
Dairy product consumption and metabolic diseases in the Di@bet.es study
Nutrients, Vol. 11, Núm. 2
2016
-
Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study
PLoS ONE, Vol. 11, Núm. 8
-
Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578
2015
-
Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice
Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425
2014
-
Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study
Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114
-
The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study
Diabetes Technology and Therapeutics, Vol. 16, Núm. 7, pp. 435-441
-
Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955
2013
-
Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863
-
Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study
Clinical Science, Vol. 124, Núm. 4, pp. 269-277
-
Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study
European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10
-
Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study
European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916
-
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study
Acta Diabetologica, Vol. 50, Núm. 4, pp. 615-623
2012
-
Detection of hypomethylation syndrome among patients with epigenetic alterations at the GNAS locus
Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 6
-
Evaluation of health-related quality of life according to carbohydrate metabolism status: A Spanish population-based study (Di@bet.es Study)
International Journal of Endocrinology, Vol. 2012
-
Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain
Clinical Endocrinology, Vol. 76, Núm. 5, pp. 719-724
2011
-
Estudio OASIS: Manejo terapéutico de la acromegalia en un escenario de práctica clínica habitual. Evaluación de la eficacia de las diversas estrategias de tratamiento aplicadas
Endocrinologia y Nutricion, Vol. 58, Núm. 9, pp. 478-486
2010
-
Hipopituitarismo y neurohipófisis
Endocrinologia y Nutricion, Vol. 57, Núm. SUPPL. 1, pp. 30-34